Antidepressant Medication Augmented With Cognitive-Behavioral Therapy for Generalized Anxiety Disorder in Older Adults

Cognitive-behavioral therapy (CBT) enhanced antidepressant treatment in older adults by reducing worrying in the short term and sustaining remission without long-term pharmacotherapy. Adding CBT may be a useful treatment option for some patients as standard first-line treatment. ObjectiveGeneralized...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of psychiatry 2013-07, Vol.170 (7), p.782-789
Hauptverfasser: Wetherell, Julie Loebach, Petkus, Andrew J., White, Kamila S., Nguyen, Hoang, Kornblith, Sander, Andreescu, Carmen, Zisook, Sidney, Lenze, Eric J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 789
container_issue 7
container_start_page 782
container_title The American journal of psychiatry
container_volume 170
creator Wetherell, Julie Loebach
Petkus, Andrew J.
White, Kamila S.
Nguyen, Hoang
Kornblith, Sander
Andreescu, Carmen
Zisook, Sidney
Lenze, Eric J.
description Cognitive-behavioral therapy (CBT) enhanced antidepressant treatment in older adults by reducing worrying in the short term and sustaining remission without long-term pharmacotherapy. Adding CBT may be a useful treatment option for some patients as standard first-line treatment. ObjectiveGeneralized anxiety disorder is common among older adults and leads to diminished health and cognitive functioning. Although antidepressant medications are efficacious, many elderly individuals require augmentation treatment. Furthermore, little is known about maintenance strategies for older people. The authors examined whether sequenced treatment combining pharmacotherapy and cognitive-behavioral therapy (CBT) boosts response and prevents relapse in older adults with generalized anxiety disorder.MethodParticipants were individuals at least 60 years of age with generalized anxiety disorder (N=73) who were recruited from outpatient clinics at three sites. Participants received 12 weeks of open-label escitalopram and were then randomly assigned to one of four conditions: 16 weeks of escitalopram (10–20 mg/day) plus modular CBT, followed by 28 weeks of maintenance escitalopram; escitalopram alone, followed by maintenance escitalopram; escitalopram plus CBT, followed by pill placebo; and escitalopram alone, followed by placebo.ResultsEscitalopram augmented with CBT increased response rates on the Penn State Worry Questionnaire but not on the Hamilton Anxiety Rating Scale compared with escitalopram alone. Both escitalopram and CBT prevented relapse compared with placebo.ConclusionsThis study demonstrates effective strategies for treatment of generalized anxiety disorder in older adults. The sequence of antidepressant medication augmented with CBT leads to worry reduction in the short-term. Continued medication prevents relapse, but for many individuals, CBT would allow sustained remission without requiring long-term pharmacotherapy.
doi_str_mv 10.1176/appi.ajp.2013.12081104
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4090227</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3090293011</sourcerecordid><originalsourceid>FETCH-LOGICAL-a549t-61bea600c14cffb645b7cb6ab72352dfb6d026771f2a400bc7447d3f4f55ecac3</originalsourceid><addsrcrecordid>eNqFkk2P0zAQhi0EYsvCX1hZQkhcUvwZJxekUGBBWrSXRXCzHMdpXaV2sJ2K8utxaHcXOMDJX8-8M-N5AbjAaImxKF-pcbRLtR2XBGG6xARVGCP2ACwwp7wQhFQPwQIhRIqa069n4EmM23xEVJDH4IzQssoRYgH2jUu2M2MwMSqX4CfTWa2S9Q4203pnXDId_GLTBq782tlk96Z4YzZqb31QA7zZmKDGA-x9gJfG5cNgf-SIxn23Jh3gWxt96EyA1sHrYd403TSk-BQ86tUQzbPTeg4-v393s_pQXF1fflw1V4XirE5FiVujSoQ0Zrrv25LxVui2VK0glJMu33SIlELgniiGUKsFY6KjPes5N1ppeg5eH3XHqd2ZTud-colyDHanwkF6ZeWfL85u5NrvJUM1IkRkgZcngeC_TSYmubNRm2FQzvgpSsw5oaKsCP8_Smta5cGgOqPP_0K3fgou_4TEjNYcC4JmwfJI6eBjDKa_qxsjObtAzi6Q2QVydoG8dUEOvPi967uw27Fn4MUJUFGroQ_KaRvvOcHqmolZiB65X4nua_x3-p9rxc9i</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1439517205</pqid></control><display><type>article</type><title>Antidepressant Medication Augmented With Cognitive-Behavioral Therapy for Generalized Anxiety Disorder in Older Adults</title><source>MEDLINE</source><source>American Psychiatric Publishing Journals (1997-Present)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Wetherell, Julie Loebach ; Petkus, Andrew J. ; White, Kamila S. ; Nguyen, Hoang ; Kornblith, Sander ; Andreescu, Carmen ; Zisook, Sidney ; Lenze, Eric J.</creator><creatorcontrib>Wetherell, Julie Loebach ; Petkus, Andrew J. ; White, Kamila S. ; Nguyen, Hoang ; Kornblith, Sander ; Andreescu, Carmen ; Zisook, Sidney ; Lenze, Eric J.</creatorcontrib><description>Cognitive-behavioral therapy (CBT) enhanced antidepressant treatment in older adults by reducing worrying in the short term and sustaining remission without long-term pharmacotherapy. Adding CBT may be a useful treatment option for some patients as standard first-line treatment. ObjectiveGeneralized anxiety disorder is common among older adults and leads to diminished health and cognitive functioning. Although antidepressant medications are efficacious, many elderly individuals require augmentation treatment. Furthermore, little is known about maintenance strategies for older people. The authors examined whether sequenced treatment combining pharmacotherapy and cognitive-behavioral therapy (CBT) boosts response and prevents relapse in older adults with generalized anxiety disorder.MethodParticipants were individuals at least 60 years of age with generalized anxiety disorder (N=73) who were recruited from outpatient clinics at three sites. Participants received 12 weeks of open-label escitalopram and were then randomly assigned to one of four conditions: 16 weeks of escitalopram (10–20 mg/day) plus modular CBT, followed by 28 weeks of maintenance escitalopram; escitalopram alone, followed by maintenance escitalopram; escitalopram plus CBT, followed by pill placebo; and escitalopram alone, followed by placebo.ResultsEscitalopram augmented with CBT increased response rates on the Penn State Worry Questionnaire but not on the Hamilton Anxiety Rating Scale compared with escitalopram alone. Both escitalopram and CBT prevented relapse compared with placebo.ConclusionsThis study demonstrates effective strategies for treatment of generalized anxiety disorder in older adults. The sequence of antidepressant medication augmented with CBT leads to worry reduction in the short-term. Continued medication prevents relapse, but for many individuals, CBT would allow sustained remission without requiring long-term pharmacotherapy.</description><identifier>ISSN: 0002-953X</identifier><identifier>EISSN: 1535-7228</identifier><identifier>DOI: 10.1176/appi.ajp.2013.12081104</identifier><identifier>PMID: 23680817</identifier><identifier>CODEN: AJPSAO</identifier><language>eng</language><publisher>Arlington, VA: American Psychiatric Association</publisher><subject>Adult and adolescent clinical studies ; Aged ; Antidepressants ; Antidepressive Agents, Second-Generation - therapeutic use ; Anxiety ; Anxiety Disorders - drug therapy ; Anxiety Disorders - therapy ; Anxiety disorders. Neuroses ; Behavior therapy. Cognitive therapy ; Biological and medical sciences ; Citalopram - therapeutic use ; Clinical outcomes ; Cognitive therapy ; Cognitive Therapy - methods ; Combined Modality Therapy ; Drug therapy ; Female ; Humans ; Male ; Medical sciences ; Miscellaneous ; Neuropharmacology ; Older people ; Pharmacology. Drug treatments ; Psychiatric Status Rating Scales ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychopharmacology ; Surveys and Questionnaires ; Treatments</subject><ispartof>The American journal of psychiatry, 2013-07, Vol.170 (7), p.782-789</ispartof><rights>Copyright © 2013 by the American Psychiatric Association 2013</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2013 by the American Psychiatric Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a549t-61bea600c14cffb645b7cb6ab72352dfb6d026771f2a400bc7447d3f4f55ecac3</citedby><cites>FETCH-LOGICAL-a549t-61bea600c14cffb645b7cb6ab72352dfb6d026771f2a400bc7447d3f4f55ecac3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://psychiatryonline.org/doi/epdf/10.1176/appi.ajp.2013.12081104$$EPDF$$P50$$Gappi$$H</linktopdf><linktohtml>$$Uhttps://psychiatryonline.org/doi/full/10.1176/appi.ajp.2013.12081104$$EHTML$$P50$$Gappi$$H</linktohtml><link.rule.ids>230,314,776,780,881,2841,21606,21607,21608,27903,27904,77540,77545</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=27499474$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23680817$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wetherell, Julie Loebach</creatorcontrib><creatorcontrib>Petkus, Andrew J.</creatorcontrib><creatorcontrib>White, Kamila S.</creatorcontrib><creatorcontrib>Nguyen, Hoang</creatorcontrib><creatorcontrib>Kornblith, Sander</creatorcontrib><creatorcontrib>Andreescu, Carmen</creatorcontrib><creatorcontrib>Zisook, Sidney</creatorcontrib><creatorcontrib>Lenze, Eric J.</creatorcontrib><title>Antidepressant Medication Augmented With Cognitive-Behavioral Therapy for Generalized Anxiety Disorder in Older Adults</title><title>The American journal of psychiatry</title><addtitle>Am J Psychiatry</addtitle><description>Cognitive-behavioral therapy (CBT) enhanced antidepressant treatment in older adults by reducing worrying in the short term and sustaining remission without long-term pharmacotherapy. Adding CBT may be a useful treatment option for some patients as standard first-line treatment. ObjectiveGeneralized anxiety disorder is common among older adults and leads to diminished health and cognitive functioning. Although antidepressant medications are efficacious, many elderly individuals require augmentation treatment. Furthermore, little is known about maintenance strategies for older people. The authors examined whether sequenced treatment combining pharmacotherapy and cognitive-behavioral therapy (CBT) boosts response and prevents relapse in older adults with generalized anxiety disorder.MethodParticipants were individuals at least 60 years of age with generalized anxiety disorder (N=73) who were recruited from outpatient clinics at three sites. Participants received 12 weeks of open-label escitalopram and were then randomly assigned to one of four conditions: 16 weeks of escitalopram (10–20 mg/day) plus modular CBT, followed by 28 weeks of maintenance escitalopram; escitalopram alone, followed by maintenance escitalopram; escitalopram plus CBT, followed by pill placebo; and escitalopram alone, followed by placebo.ResultsEscitalopram augmented with CBT increased response rates on the Penn State Worry Questionnaire but not on the Hamilton Anxiety Rating Scale compared with escitalopram alone. Both escitalopram and CBT prevented relapse compared with placebo.ConclusionsThis study demonstrates effective strategies for treatment of generalized anxiety disorder in older adults. The sequence of antidepressant medication augmented with CBT leads to worry reduction in the short-term. Continued medication prevents relapse, but for many individuals, CBT would allow sustained remission without requiring long-term pharmacotherapy.</description><subject>Adult and adolescent clinical studies</subject><subject>Aged</subject><subject>Antidepressants</subject><subject>Antidepressive Agents, Second-Generation - therapeutic use</subject><subject>Anxiety</subject><subject>Anxiety Disorders - drug therapy</subject><subject>Anxiety Disorders - therapy</subject><subject>Anxiety disorders. Neuroses</subject><subject>Behavior therapy. Cognitive therapy</subject><subject>Biological and medical sciences</subject><subject>Citalopram - therapeutic use</subject><subject>Clinical outcomes</subject><subject>Cognitive therapy</subject><subject>Cognitive Therapy - methods</subject><subject>Combined Modality Therapy</subject><subject>Drug therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Neuropharmacology</subject><subject>Older people</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychiatric Status Rating Scales</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Surveys and Questionnaires</subject><subject>Treatments</subject><issn>0002-953X</issn><issn>1535-7228</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkk2P0zAQhi0EYsvCX1hZQkhcUvwZJxekUGBBWrSXRXCzHMdpXaV2sJ2K8utxaHcXOMDJX8-8M-N5AbjAaImxKF-pcbRLtR2XBGG6xARVGCP2ACwwp7wQhFQPwQIhRIqa069n4EmM23xEVJDH4IzQssoRYgH2jUu2M2MwMSqX4CfTWa2S9Q4203pnXDId_GLTBq782tlk96Z4YzZqb31QA7zZmKDGA-x9gJfG5cNgf-SIxn23Jh3gWxt96EyA1sHrYd403TSk-BQ86tUQzbPTeg4-v393s_pQXF1fflw1V4XirE5FiVujSoQ0Zrrv25LxVui2VK0glJMu33SIlELgniiGUKsFY6KjPes5N1ppeg5eH3XHqd2ZTud-colyDHanwkF6ZeWfL85u5NrvJUM1IkRkgZcngeC_TSYmubNRm2FQzvgpSsw5oaKsCP8_Smta5cGgOqPP_0K3fgou_4TEjNYcC4JmwfJI6eBjDKa_qxsjObtAzi6Q2QVydoG8dUEOvPi967uw27Fn4MUJUFGroQ_KaRvvOcHqmolZiB65X4nua_x3-p9rxc9i</recordid><startdate>20130701</startdate><enddate>20130701</enddate><creator>Wetherell, Julie Loebach</creator><creator>Petkus, Andrew J.</creator><creator>White, Kamila S.</creator><creator>Nguyen, Hoang</creator><creator>Kornblith, Sander</creator><creator>Andreescu, Carmen</creator><creator>Zisook, Sidney</creator><creator>Lenze, Eric J.</creator><general>American Psychiatric Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>5PM</scope></search><sort><creationdate>20130701</creationdate><title>Antidepressant Medication Augmented With Cognitive-Behavioral Therapy for Generalized Anxiety Disorder in Older Adults</title><author>Wetherell, Julie Loebach ; Petkus, Andrew J. ; White, Kamila S. ; Nguyen, Hoang ; Kornblith, Sander ; Andreescu, Carmen ; Zisook, Sidney ; Lenze, Eric J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a549t-61bea600c14cffb645b7cb6ab72352dfb6d026771f2a400bc7447d3f4f55ecac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult and adolescent clinical studies</topic><topic>Aged</topic><topic>Antidepressants</topic><topic>Antidepressive Agents, Second-Generation - therapeutic use</topic><topic>Anxiety</topic><topic>Anxiety Disorders - drug therapy</topic><topic>Anxiety Disorders - therapy</topic><topic>Anxiety disorders. Neuroses</topic><topic>Behavior therapy. Cognitive therapy</topic><topic>Biological and medical sciences</topic><topic>Citalopram - therapeutic use</topic><topic>Clinical outcomes</topic><topic>Cognitive therapy</topic><topic>Cognitive Therapy - methods</topic><topic>Combined Modality Therapy</topic><topic>Drug therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Neuropharmacology</topic><topic>Older people</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychiatric Status Rating Scales</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Surveys and Questionnaires</topic><topic>Treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wetherell, Julie Loebach</creatorcontrib><creatorcontrib>Petkus, Andrew J.</creatorcontrib><creatorcontrib>White, Kamila S.</creatorcontrib><creatorcontrib>Nguyen, Hoang</creatorcontrib><creatorcontrib>Kornblith, Sander</creatorcontrib><creatorcontrib>Andreescu, Carmen</creatorcontrib><creatorcontrib>Zisook, Sidney</creatorcontrib><creatorcontrib>Lenze, Eric J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal of psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wetherell, Julie Loebach</au><au>Petkus, Andrew J.</au><au>White, Kamila S.</au><au>Nguyen, Hoang</au><au>Kornblith, Sander</au><au>Andreescu, Carmen</au><au>Zisook, Sidney</au><au>Lenze, Eric J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antidepressant Medication Augmented With Cognitive-Behavioral Therapy for Generalized Anxiety Disorder in Older Adults</atitle><jtitle>The American journal of psychiatry</jtitle><addtitle>Am J Psychiatry</addtitle><date>2013-07-01</date><risdate>2013</risdate><volume>170</volume><issue>7</issue><spage>782</spage><epage>789</epage><pages>782-789</pages><issn>0002-953X</issn><eissn>1535-7228</eissn><coden>AJPSAO</coden><abstract>Cognitive-behavioral therapy (CBT) enhanced antidepressant treatment in older adults by reducing worrying in the short term and sustaining remission without long-term pharmacotherapy. Adding CBT may be a useful treatment option for some patients as standard first-line treatment. ObjectiveGeneralized anxiety disorder is common among older adults and leads to diminished health and cognitive functioning. Although antidepressant medications are efficacious, many elderly individuals require augmentation treatment. Furthermore, little is known about maintenance strategies for older people. The authors examined whether sequenced treatment combining pharmacotherapy and cognitive-behavioral therapy (CBT) boosts response and prevents relapse in older adults with generalized anxiety disorder.MethodParticipants were individuals at least 60 years of age with generalized anxiety disorder (N=73) who were recruited from outpatient clinics at three sites. Participants received 12 weeks of open-label escitalopram and were then randomly assigned to one of four conditions: 16 weeks of escitalopram (10–20 mg/day) plus modular CBT, followed by 28 weeks of maintenance escitalopram; escitalopram alone, followed by maintenance escitalopram; escitalopram plus CBT, followed by pill placebo; and escitalopram alone, followed by placebo.ResultsEscitalopram augmented with CBT increased response rates on the Penn State Worry Questionnaire but not on the Hamilton Anxiety Rating Scale compared with escitalopram alone. Both escitalopram and CBT prevented relapse compared with placebo.ConclusionsThis study demonstrates effective strategies for treatment of generalized anxiety disorder in older adults. The sequence of antidepressant medication augmented with CBT leads to worry reduction in the short-term. Continued medication prevents relapse, but for many individuals, CBT would allow sustained remission without requiring long-term pharmacotherapy.</abstract><cop>Arlington, VA</cop><pub>American Psychiatric Association</pub><pmid>23680817</pmid><doi>10.1176/appi.ajp.2013.12081104</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-953X
ispartof The American journal of psychiatry, 2013-07, Vol.170 (7), p.782-789
issn 0002-953X
1535-7228
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4090227
source MEDLINE; American Psychiatric Publishing Journals (1997-Present); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Adult and adolescent clinical studies
Aged
Antidepressants
Antidepressive Agents, Second-Generation - therapeutic use
Anxiety
Anxiety Disorders - drug therapy
Anxiety Disorders - therapy
Anxiety disorders. Neuroses
Behavior therapy. Cognitive therapy
Biological and medical sciences
Citalopram - therapeutic use
Clinical outcomes
Cognitive therapy
Cognitive Therapy - methods
Combined Modality Therapy
Drug therapy
Female
Humans
Male
Medical sciences
Miscellaneous
Neuropharmacology
Older people
Pharmacology. Drug treatments
Psychiatric Status Rating Scales
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychopharmacology
Surveys and Questionnaires
Treatments
title Antidepressant Medication Augmented With Cognitive-Behavioral Therapy for Generalized Anxiety Disorder in Older Adults
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T01%3A34%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antidepressant%20Medication%20Augmented%20With%20Cognitive-Behavioral%20Therapy%20for%20Generalized%20Anxiety%20Disorder%20in%20Older%20Adults&rft.jtitle=The%20American%20journal%20of%20psychiatry&rft.au=Wetherell,%20Julie%20Loebach&rft.date=2013-07-01&rft.volume=170&rft.issue=7&rft.spage=782&rft.epage=789&rft.pages=782-789&rft.issn=0002-953X&rft.eissn=1535-7228&rft.coden=AJPSAO&rft_id=info:doi/10.1176/appi.ajp.2013.12081104&rft_dat=%3Cproquest_pubme%3E3090293011%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1439517205&rft_id=info:pmid/23680817&rfr_iscdi=true